논문번호 | 90 | ||
논문제목(영문) | Novel Polymer-Free Everolimus-Eluting Stent Fabricated using Femtosecond Laser Improves Re-endothelialization and Anti-inflammation | ||
국내외구분 | 국외 | SCI여부 | SCI(E) |
연구책임자역할 | 교신저자 | ||
주저자명 | Bae IH | ||
교신저자명 | Jeong MH | ||
공동저자명 | Bae IH, Jeong MH, Lim KS, Park DS, Shim JW, Park JK, Oh KH, Jin MR, Sim DS. | ||
게제년월일 | 2018-05-09 | ||
ISSN | 2045-2322 | ||
Impact Factor | 4.259 | ||
학술지명 | Scientific reports | ||
서지사항 | 0집 / 8권 / 1호, 페이지(7383 - 7394) | ||
요약초록문 (Abstract) 입력 |
The aim of this study was to fabricate a novel polymer-free everolimus-eluting stent with nanostructure using a femtosecond laser (FSL). The stent were coated with everolimus (EVL) using FSL and electrospinning processes. The surface was rendered hydrophobic, which negatively affected both platelet adhesion (82.1%) and smooth muscle cell response. Animal study was performed using a porcine coronary restenosis model. The study groups were divided into 1) bare metal stent (BMS), 2) poly(L-lactide) (PLA)-based EVL drug eluting stent (DES), 3) commercial EVL-eluting DES, and 4) FSL-EVL-DES. After four weeks of stent implantation, various analyses were performed. Quantitative analysis showed that the amount of in-stent restenosis was higher in the BMS group (BMS; 27.8 ± 2.68%, PLA-based DES; 12.2 ± 0.57%, commercial DES; 9.8 ± 0.28%, and FSL-DES; 9.3 ± 0.25%, n = 10, p < 0.05). Specifically, the inflammation score was reduced in the FSL-DES group (1.9 ± 0.39, n = 10, p < 0.05). The increment in re-endothelialization in the FSL-DES group was confirmed by immunofluorescence analysis. Taken together, the novel polymer-free EVL-eluting stent fabricated using FSL can be an innovative DES with reduced risk of ISR, thrombosis, and inflammation. | ||
파일 |
90-Novel Polymer-Free Everolimus-Eluting Stent Fabricated using Femtosecond Laser Improves Re-endothelialization and Anti-inflammation.pdf (4.1M) DATE : 2018-05-28 11:24:06 |
전라남도 장성군 남면 삼태리 산 109 나노바이오연구원 3층 306호 TEL : 061-392-6243 Fax: 061-392-6243
Copyright ⓒ 2014 Korea Cardiovascular Stent Research Institute. All right Reserved